Genesis Molecular AI
Genesis Molecular AI applies its GEMS platform to design potent, selective small-molecule drug candidates for challenging protein targets. The company combines generative molecular AI (including the Pearl diffusion model), deep neural networks, physics-based simulation, and scalable computing infrastructure to generate and predict molecular properties and optimize leads. GEMS is used in iterative cycles of in silico design, synthesis prioritization, and experimental testing and is deployed via research collaborations with pharmaceutical and biotech partners. The firm operates as a biotech AI platform company focused on discovery-stage programs and milestone-based research collaborations across therapeutic areas.
Genesis Molecular AI
Genesis Molecular AI applies its GEMS platform to design potent, selective small-molecule drug candidates for challenging protein targets. The company combines generative molecular AI (including the Pearl diffusion model), deep neural networks, physics-based simulation, and scalable computing infrastructure to generate and predict molecular properties and optimize leads. GEMS is used in iterative cycles of in silico design, synthesis prioritization, and experimental testing and is deployed via research collaborations with pharmaceutical and biotech partners. The firm operates as a biotech AI platform company focused on discovery-stage programs and milestone-based research collaborations across therapeutic areas.